G1 Therapeutics (GTHX) stock forecast for 2025. Forecast tables and graphs.

G1 Therapeutics (GTHX) stock forecast for 2025

Last update: 05-22-2022, 12:23

Sector: Healthcare

The share price of G1 Therapeutics, Inc. (GTHX) now

What analysts predict:: $39.5

52-week high/low: $24.12 / $4.25

50/200 Day Moving Average: $7.01 / $11.08

This figure corresponds to the average price over the previous 50/200 days. For G1 Therapeutics stocks, the 50-day moving average is the resistance level today.

For G1 Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in G1 Therapeutics stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the G1 Therapeutics stock price in 2025. How much will one G1 Therapeutics share be worth in 2025?

Is it worth taking profit / loss on G1 Therapeutics stock now or waiting? What are analysts' forecasts for G1 Therapeutics stock?

We forecast G1 Therapeutics stock performance using neural networks based on historical data on G1 Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The G1 Therapeutics stock prediction results are shown below and presented as a graph, table and text information.

G1 Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for G1 Therapeutics analysts is $39.5.

Today 200 Day Moving Average is the resistance level (11.08 $).

50 Day Moving Average is the resistance level (7.01 $).




Historical and forecast chart of G1 Therapeutics stock

The chart below shows the historical price of G1 Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the G1 Therapeutics stock price can be found in the table below.

G1 Therapeutics (GTHX) Forecast for 2025

Month Target Pes. Opt. Vol., %
Jan 6.07 4.88 6.66 26.82 %
Feb 6.85 5.96 7.77 23.31 %
Mar 7.55 6.39 8.26 22.70 %
Apr 8.12 7.64 9.15 16.53 %
May 7.37 5.84 8.03 27.27 %
Jun 6.52 5.34 7.82 31.73 %
Jul 6.18 5.26 7.40 28.87 %
Aug 5.97 4.73 7.14 33.83 %
Sep 5.77 4.67 6.83 31.71 %
Oct 5.35 4.86 6.19 21.48 %
Nov 4.63 3.65 5.43 32.69 %
Dec 4.32 3.87 5.21 25.71 %

G1 Therapeutics information and performance

G1 Therapeutics, Inc. is a clinical biopharmaceutical company that develops and delivers innovative treatments that improve the lives of people with cancer.

Official site of the company

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization: 225 058 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -105 136 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -4.032

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.515

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.008

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 42705500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

G1 Therapeutics price target for 2021 by month


Target values for the price of one G1 Therapeutics share for Jan 2025.

The weighted average target price per G1 Therapeutics share in Jan 2025 is: 6.07. In Jan, the positive dynamics for Momo shares will prevail with possible monthly volatility of 26.823% volatility is expected.

Pessimistic target level: 4.88

Optimistic target level: 6.66


Target values for the price of one G1 Therapeutics share for Feb 2025.

The weighted average target price per G1 Therapeutics share in Feb 2025 is: 6.85. In Feb, the positive dynamics for Momo shares will prevail with possible monthly volatility of 23.313% volatility is expected.

Pessimistic target level: 5.96

Optimistic target level: 7.77


Target values for the price of one G1 Therapeutics share for Mar 2025.

The weighted average target price per G1 Therapeutics share in Mar 2025 is: 7.55. In Mar, the positive dynamics for Momo shares will prevail with possible monthly volatility of 22.695% volatility is expected.

Pessimistic target level: 6.39

Optimistic target level: 8.26


Target values for the price of one G1 Therapeutics share for Apr 2025.

The weighted average target price per G1 Therapeutics share in Apr 2025 is: 8.12. In Apr, the positive dynamics for Momo shares will prevail with possible monthly volatility of 16.532% volatility is expected.

Pessimistic target level: 7.64

Optimistic target level: 9.15


Target values for the price of one G1 Therapeutics share for May 2025.

The weighted average target price per G1 Therapeutics share in May 2025 is: 7.37. In May, the negative dynamics for Momo shares will prevail with possible monthly volatility of 27.270% volatility is expected.

Pessimistic target level: 5.84

Optimistic target level: 8.03


Target values for the price of one G1 Therapeutics share for Jun 2025.

The weighted average target price per G1 Therapeutics share in Jun 2025 is: 6.52. In Jun, the negative dynamics for Momo shares will prevail with possible monthly volatility of 31.730% volatility is expected.

Pessimistic target level: 5.34

Optimistic target level: 7.82


Target values for the price of one G1 Therapeutics share for Jul 2025.

The weighted average target price per G1 Therapeutics share in Jul 2025 is: 6.18. In Jul, the negative dynamics for Momo shares will prevail with possible monthly volatility of 28.870% volatility is expected.

Pessimistic target level: 5.26

Optimistic target level: 7.40


Target values for the price of one G1 Therapeutics share for Aug 2025.

The weighted average target price per G1 Therapeutics share in Aug 2025 is: 5.97. In Aug, the negative dynamics for Momo shares will prevail with possible monthly volatility of 33.832% volatility is expected.

Pessimistic target level: 4.73

Optimistic target level: 7.14


Target values for the price of one G1 Therapeutics share for Sep 2025.

The weighted average target price per G1 Therapeutics share in Sep 2025 is: 5.77. In Sep, the negative dynamics for Momo shares will prevail with possible monthly volatility of 31.708% volatility is expected.

Pessimistic target level: 4.67

Optimistic target level: 6.83


Target values for the price of one G1 Therapeutics share for Oct 2025.

The weighted average target price per G1 Therapeutics share in Oct 2025 is: 5.35. In Oct, the negative dynamics for Momo shares will prevail with possible monthly volatility of 21.477% volatility is expected.

Pessimistic target level: 4.86

Optimistic target level: 6.19


Target values for the price of one G1 Therapeutics share for Nov 2025.

The weighted average target price per G1 Therapeutics share in Nov 2025 is: 4.63. In Nov, the negative dynamics for Momo shares will prevail with possible monthly volatility of 32.691% volatility is expected.

Pessimistic target level: 3.65

Optimistic target level: 5.43


Target values for the price of one G1 Therapeutics share for Dec 2025.

The weighted average target price per G1 Therapeutics share in Dec 2025 is: 4.32. In Dec, the negative dynamics for Momo shares will prevail with possible monthly volatility of 25.706% volatility is expected.

Pessimistic target level: 3.87

Optimistic target level: 5.21




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.